Osteosarcoma in Children

What is Osteosarcoma?

Osteosarcoma is a rare, malignant type of pediatric sarcoma of the bone. While it is an uncommon cancer, it is one of the most common types of pediatric bone tumors. It is diagnosed in approximately 400 children, older teens, and young adults annually in the United States.1

Osteosarcoma usually strikes boys more often than girls and often presents in individuals between 10-20 years of age. Tumors usually first appear in the wider ends of the long bones in the body; they most often manifest in the humerus bones in the arms and the femur and tibia in the legs. In some cases, it can originate in the flat bones that surround and protect organs like the pelvis, ribs, and skull.

An aggressive type of childhood cancer, osteosarcoma can spread quickly to other parts of the body, like other bones, tissues, and organs (primarily the lungs). In up to 20% of patients, osteosarcoma tumors have already spread from the origination site by the time of initial diagnosis.

Osteosarcoma Symptoms, Causes and Risk Factors 

The cause of osteosarcoma is usually unknown, but recent research suggests that genetic factors may play a role in addition to patients previously treated with radiation therapy for other cancers. Most specifically, patients previously treated for cancers like retinoblastoma and other childhood cancers, as well as having a family history with various kinds of cancer (breast, leukemia, brain tumors, and other kinds of soft-tissue tumors), can increase a child’s chances of developing this type of bone cancer. Additionally, 3-4% of children diagnosed with osteosarcoma have germline mutations that are associated with a predisposition to developing childhood cancer early in life.

This bone cancer can mask itself as a common childhood injury or growing pain, which can delay diagnosis. However, there are sometimes additional osteosarcoma symptoms:

     • Pain, tenderness, swelling, and/or stiffness in the affected area is one of the most common bone cancer symptoms

     • Progressively worse, radiating pain extending outward from the tumor site 

     • Aggressive pain that may awaken the child from a deep sleep

     • Weakened bones and/or fracture

     • Fatigue, weight loss, and/or anemia

     • Loss of motor function and/or decreased ability to walk

Diagnosis of Osteosarcoma Childhood Cancer

Getting a rapid diagnosis is important to quickly begin a treatment plan and prevent the possibility of spread. Clinical specialists can use a variety of tests to diagnose and assess the disease progression:

     • X-rays

     • Magnetic resonance imaging (MRI)

     • Computed tomography (CT) scan

     • EOS imaging

     • Radioisotope bone scans, which can help locate areas of abnormal growth

     • Positron emission tomography (PET) scan

     • Blood tests

     • Needle biopsy

Treatment and Prognosis of Osteosarcoma Bone Cancer


Malignant bone cancer tumors like osteosarcoma require very active and aggressive treatment that usually includes a combination of surgery and chemotherapy.

     • Surgery: Surgery is used to remove osteosarcoma tumors to try to restore the function of the affected area. Up to 90% of children with this type of bone cancer are eligible for reconstructive, limb-saving surgery through a variety of techniques.

     • Chemotherapy: Osteosarcoma patients always undergo targeted chemotherapy. Depending on the case, the patient may be administered chemotherapy before and/or after surgery to prevent spread.

As with all childhood cancers, the long-term prognosis and survival vary from case to case. However, rapid medical assessment and an aggressive therapy plan can improve the prognosis. 

     • If the affected area is localized and has not spread to other areas of the body, the long-term survival rate tends to be 70 to 75%.

     • If the osteosarcoma has spread to the lungs and/or other bones at diagnosis, the long-term survival rate is around 30%.

Childhood Cancer Research in Osteosarcoma

Continued clinical research of osteosarcoma helps scientists study the behavior and biology of osteosarcoma along tumor cell lines and laboratory models. Additionally, clinical trials provide the opportunity to test new treatments and therapies that may be more effective in treating osteosarcoma. Some of the latest research in osteosarcoma include:

     • The potential use of immunotherapy and targeted therapies such as tyrosine kinase inhibitors.2

     • Examination of genetic markers that can cause chemotherapy resistance, highlighting the need for more research to develop effective treatments.3

     • Hydrogels loaded with chemotherapeutic drugs that showed promising results through site-specific therapy.4

     • A study comparing the clinical outcomes of six different drugs, examining how future trials can be designed to improve response rates and decrease toxicity.5

By investing in early investigational research, both pre-clinical and clinical for this bone cancer, Solving Kids’ Cancer is dedicated to increasing the prognosis for children with pediatric osteosarcoma. 

Your gift to Solving Kids’ Cancer changes the lives of children with osteosarcoma by making better treatment options possible for the very youngest of cancer patients — because every kid deserves to grow up®.

A pink button that says `` help solve kids ' cancer ''
Sources
1 Educational Case: Primary Osteosarcoma – https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6343432/
2 Osteosarcoma: Current Concepts and Evolutions in Management Principles – https://pubmed.ncbi.nlm.nih.gov/37109122/
3 A Systematic Review of the Heterogenous Gene Expression Patterns Associated with Multidrug Chemoresistance in Conventional Osteosarcoma – https://pubmed.ncbi.nlm.nih.gov/37107591/
4 The Use of Hydrogels for the Treatment of Bone Osteosarcoma via Localized Drug-Delivery and Tissue Regeneration: A Narrative Review – https://pubmed.ncbi.nlm.nih.gov/37102886/
5 Recent advances on anti-angiogenic multi-receptor tyrosine kinase inhibitors in osteosarcoma and Ewing sarcoma https://pubmed.ncbi.nlm.nih.gov/36994209/
By Kristi McKay December 2, 2024
Ways to Give Back During the Holidays
A man and a little girl are sitting in front of a wooden wall.
By duda November 20, 2024
Ahana’s Story of Strength with High-Risk Neuroblastoma Every day, over 1,000 children worldwide are diagnosed with cancer,1 and for many families, that diagnosis means facing an uncertain future. At just 20 months old, Ahana was diagnosed with a rare and aggressive cancer that had already spread through her small body. Her family’s search for life-saving childhood cancer treatments led them from South Africa to Spain and possibly toward a clinical trial in New York. Ahana’s journey shows the importance of supporting organizations like Solving Kids’ Cancer, which works to find, fund, and advocate for advanced treatments that give hope to families fighting against tough-to-treat rare pediatric cancers.
A poster for 2024 year in review for solving kids ' cancer
November 11, 2024
Advancing Childhood Cancer Research: SKC’s 2024 Milestones
A group of children are holding a sign that says
October 1, 2024
Lace Up for Kids: Your Impact on Childhood Cancer Research At Solving Kids’ Cancer, our mission has always been driven by hope — hope for better treatments, hope for breakthroughs, and most importantly, hope for every child fighting cancer. This year’s Lace Up for Kids campaign was nothing short of inspiring. Together, we’ve raised over $264,000 across the entire campaign, funding innovative childhood cancer research and providing more treatment options for children in need.  From coast to coast, nearly 4,000 participants have stepped up to lace up their gold shoelaces and make a difference. Whether it was through schools, sports teams, or community groups, the show of support has been overwhelming throughout the years. Over 7,823 donations have been made to accelerate new treatments, and the hashtag #CareWearShare has been used 13,864 times, spreading the message far and wide!
A girl is standing in front of a car in a parking lot.
September 2, 2024
Gold Laces for Childhood Cancer Awareness Month: Erin’s Story 
A group of children are standing in a circle with their shoes on the floor.
August 8, 2024
Smithtown Goes Gold for Childhood Cancer Awareness Month!
A poster for lace up for kids with a butterfly on it
August 6, 2024
Childhood Cancer Awareness Month: Lace Up for Kids 2024
A man standing on top of a mountain with the words osteosarcoma survivor to surgeon dr. kurt weiss ' story
August 1, 2024
Osteosarcoma Survivor to Surgeon: Dr. Kurt Weiss’ Story
By Kristi McKay July 4, 2024
A Quick Guide to Your Role as a Parent Advocate 
Jacob 's journey : a childhood cancer survivor 's story
May 10, 2024
Jacob’s Journey: A Childhood Cancer Survivor’s Story Every battle has its heroes, and among the bravest are young children like Jacob Mozer, who faced stage 4 high-risk neuroblastoma when he was barely old enough to walk. Diagnosed at only 16 months old, Jacob’s early years were filled with constant medical appointments and intense treatments. Despite these challenges, today, Jacob is a shining example of the remarkable progress in pediatric oncology. He’s not merely surviving; he’s thriving as a pharmacy resident, driven to give back to the medical community that gave him a second chance at life. During National Cancer Survivors Month this June, we honor and celebrate fighters like Jacob who have battled cancer and emerged stronger. This month also serves to amplify the conversation about pediatric cancer survivorship and push for vital research that continues to save lives. Solving Kids’ Cancer (SKC) plays an essential role in this effort, supporting children like Jacob by funding crucial clinical trials that enhance survival rates and improve the quality of life for those fighting fatal childhood cancers.
More Posts